South Korea Fines GSK $2.6M Over Pay-For-Delay Deal
GlaxoSmithKline PLC was hit Monday with a $2.6 million fine by South Korea's Fair Trade Commission over claims that the global pharmaceutical giant struck an improper deal with Seoul-based Dong-A Pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article